Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03520322 · ClinicalTrials.gov registry record · NA
A Study of a Mastoid Device in Subjects With Ménière's Disease
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03520322: Clinical Trial NA study, sponsored by University of Rochester.
NCT03520322 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03520322, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy of a mastoid treatment device in patients with active Ménière's disease that is not controlled by traditional medical management
Primary Outcome
A patient reported measure of the number of vertigo episodes they have experienced in the past month.
Interventions
- DEVICE Control Device
- DEVICE Mastoid Oscillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2024-12-04 |
| Phase | NA |
Why NCT03520322 stopped before completion
NCT03520322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Device is the first listed.
NCT03520322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03520322 about?
NCT03520322 is a clinical study titled "A Study of a Mastoid Device in Subjects With Ménière's Disease". The purpose of this study is to investigate the efficacy of a mastoid treatment device in patients with active Ménière's disease that is not controlled by traditional medical management
What is the current status of trial NCT03520322?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-01-29. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT03520322?
The interventions under investigation include: Control Device (DEVICE), Mastoid Oscillator (DEVICE).
Who is sponsoring clinical trial NCT03520322?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03520322's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI